期刊文献+

非小细胞肺癌survivin和增殖细胞核抗原表达的意义 被引量:6

Expression of survivin and proliferating cell nuclear antigen in human non-small cell lung cancer
下载PDF
导出
摘要 目的:检测非小细胞肺癌(NSCLC)组织中survivin蛋白和增殖细胞核抗原(PCNA)蛋白的表达及探讨其临床病理学意义。方法:采用免疫组织化学SP法,分别检测43例NSCLC组织、15例正常支气管上皮组织中survivin和PCNA蛋白的表达。43例均随访或追观5年以上。结果:NSCLC的survivin阳性表达率(79.1%,34/43)明显高于正常支气管上皮组织阳性表达率(13.3%,2/15)(P<0.01);Ⅲ期survivin表达明显高于Ⅰ+Ⅱ期(P<0.05);Survivin++^+++组的生存期明显较survivin-^+组短;Survivin的表达与其它临床病理参数均无明显关系(P>0.05)。NSCLC的PCNA增殖指数显著高于正常支气管黏膜上皮组织(P<0.01);增殖指数与肿瘤大小、淋巴结转移、临床分期呈正相关(P<0.01),与生存期呈负相关(P<0.01)。增殖指数与其它临床病理参数均无明显关系(P>0.05)。Survivin蛋白++^+++组中,增殖指数明显高于survivin-^+组(P<0.05)。结论:Sur-vivin和PCNA蛋白过度表达与NSCLC的发展、预后有密切关系,可作为临床评估NSCLC的进展及判断其预后的重要指标之一。Survivin在NSCLC中表达上调,与细胞增殖关系密切,提示survivin对肺癌的发生发展起重要作用。 Objective To determine the expressions of survivin and proliferating cell nuclear antigen (PCNA)in non-small cell lung cancer (NSCLC)and to explore its clinical pathological significance. Methods Immunoh.istochemical SP method was used to detect the expressions of survivin and PCNA in 43 patients with NSCLC and 15 normal epithelial tissues of the lung. PCNA labeling proliferative index was assessed. Forty-three patients with NSCLC were followed up for more than 5 years. Results The positive expression of survivin in NSCLC (79.1% ) was significantly higher than that in normal epithelial tissues of the lung (P 〈0.01 ). The survivin expression in Stage I + Ⅱ was lower than in Stage Ⅲ (P 〈 0.05). The overall survival time was significantly shorter in patients with high survivin expression than that in patients with absent or low survivin expression. The survivin expression was not related to sex, age, tumor size and site, histological type, grade, and lymphoid node metastasis (P 〉 0.05). The mean proliferative index of PCNA in NSCLC was much higher than that in normal epithelial tissues of the lung (P 〈0.01 ). A positive correlation was present between the proliferative index and the tumor size, lymph node metastase, and clinical stage (P 〈0.01 ) , while a negative correlation between the proliferative index and survival time (P 〈 0.01 ). There was no correlation between proliferative index and age, sex, site, histological type and grade. The proliferative index was larger in patients with moderate or strongpositive survivin expression than that in patients with negative or weak survivin expression (P 〈 0.05 ). Conclusion Over expression of survivin and PCNA is closely correlated to the progression and prognosis of patients with NSCLC, which is helpful to evaluate the progression of cancer and to predict the prognosis of NSCLC. The up-regulation of survivin expression and its close relationship with the cell proliferation in NSCLC suggest that survivin may play an important role in the carcinogenesis and development of lung cancer.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2005年第5期544-548,共5页 Journal of Central South University :Medical Science
关键词 非小细胞肺癌 免疫组织化学 生存素 增殖细胞核抗原 non-small cell lung cancer immuno-histochemistry survivin proliferating cell nuclear antigen
  • 相关文献

参考文献16

  • 1Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene survivin, expressed in cancer and lymphoma[J]. Nat Med, 1997, 3(8):917-921.
  • 2Travis WD, Colby TV, Corrin B, et al. WHO Histological Typing of Lung and Pleural Tumors[M]. 3rd ed. Berlin: Springer-Verlag, 1999.
  • 3Mountain CF. Revisions in the international system for staging lung cancer[J]. Chest, 1997, 111(6): 1710-1717.
  • 4Fromowitz FB, Voila MV, Chao S, et al. Ras p21 expression in the progression of breast cancer[J]. Hum Pathol, 1987, 18(12):1268-1275.
  • 5Fujishima K. Proliferative activity of mixed hyper-plastic adenomatous polyp/serrated adenoma in the large intestine measured by PCNA(proliferating cell nuclear antigen)[J]. J Gastroenterol, 1996,31:207-213.
  • 6Falleni M, Pellegrini C, Marchetti A, et al. Survivin gene expre-ssion in early-stage non-small cell lung cancer[J]. J Pathol, 2003, 200(5):620-626.
  • 7Sarela AI, Macadam RC, Farmery SM, et al. Expression of the antiapotosis gene,survivin predicts death from recurrent colorectal carcinoma[J]. Gut, 2000,46 (5):645-650.
  • 8Kato J, Kuwabara Y, Mitani M, et al. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy[J]. Int J Cancer, 2001,95(2):92-95.
  • 9Monzo M, Rosell R, Felip E, et al. A novel anti-apoptosis gene:Re-expression of survivin messenger RNA as a prognosis marker in non-small cell lung cancer[J]. J Clin Oncol, 1999,17(7):2100-2104.
  • 10张惠忠,李海刚,张华,熊利华,陈炬,吴东霞.肺癌组织中p63和Survivin蛋白的表达及其意义[J].中山医科大学学报,2003,24(1):68-70. 被引量:1

二级参考文献18

  • 1[1]Mills A A, Zheng B, Wang X J. p63 is a p53 homologue required for limb and epidermal morphogenesis[J]. Nature, 1999, 398(6729): 708.
  • 2[2]Yang A, Schweitzer R, Sun D. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development[J]. Nature, 1999,398(6729): 714.
  • 3[3]Nylander K, Coates P J, Hall P A. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions[J]. Int J Cancer, 2000,87(3):368.
  • 4[4]Park B J, Lee S J, Kim J I. Frequent alteration of p63 expression in human primary bladder carcinoma[J]. Cancer Research, 2000,60(13): 3370.
  • 5[5]Lu C D, Altieri D C, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinoma[J]. Cancer Research,1998,58(9): 1808.
  • 6[6]Crook T, Nicholls J M, Brooks L. High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)[J]? Oncogene, 2000,19(30):3439.
  • 7[8]Bao R, Connolly D C, Murphy M, et al. Activation of Cancer-specific gene expression by the survivin promoter[J]. J Natl Cancer Inst, 2002,94(7):522.
  • 8任迎春,中华结核和呼吸杂志,1999年,22卷,538页
  • 9Wang G,J Cancer Res Clin Oncol,1998年,124卷,615页
  • 10Zhang H T,J Natl Cancer Inst,1995年,87卷,213页

共引文献93

同被引文献96

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部